Delivery Order SPE2DR25D1100-SPE2DR26FCV6A
- Not listed
- The Defense Logistics Agency awarded a $6,360.82 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections on November 26, 2025, with completion targeted for November 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will...
- The Defense Logistics Agency awarded a $39,842.24 delivery order contract to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 ml pen injections. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,853.05 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. This firm fixed-price, non-set-aside contract specifies performance through AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 2, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $33,236.84 and is scheduled for completion by August 7, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child...
- The Defense Logistics Agency awarded a $20,937.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Zepbound 10 mg/0.5 mL pens (semaglutide injection), with an ultimate completion date of October 27, 2025. This non-set-aside competitive award is performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $26,577.38 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections on December 5, 2025, with completion targeted for December 8, 2025. This non-competitive delivery order represents a firm fixed price transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pre-filled pens valued at $5,398.78. This is a firm fixed price delivery order with an ultimate completion date of December 9, 2025, issued under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a $7,124.96 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order is valued at $41,790.88 with an ultimate completion date of December 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,429.68 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's broader Indefinite...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCV6ADelivery Order
The Defense Logistics Agency awarded a $5,804.63 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. This firm fixed-price contract, with an ultimate completion date of December 19, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive prime vendor agreement supporting military and veteran healthcare systems globally. This delivery order for Zepbound exemplifies the company's role in supplying specialty pharmaceutical products across multiple therapeutic domains, including diabetes and weight management medications, to support Department of Defense healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 12/17/25 |